Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: Inhibition of the core catalytic domain of human immunodeficiency virus integrase

Molecular Pharmacology

Volumn 50, Issue 4, 1996, Pages 846-855

  Robinson Jr , W Edward ^a   Cordeiro, Mara ^b   Abdel Malek, Samia ^c   Jia, Qi ^c   Chow, Samson A ^b   Reinecke, Manfred G ^c   Mitchell, William M ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TEXAS CHRISTIAN UNIVERSITY   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICAFFEOYLQUINIC ACID; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CAFFEIC ACID DERIVATIVE; CHLOROGENIC ACID; CICHORIC ACID; COMPLEMENTARY DNA; CYNARINE; DICAFFEOYLQUINIC ACID DERIVATIVE; INTEGRASE; ISOCHLOROGENIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR MODEL; PRIORITY JOURNAL; VIRUS INHIBITION;

AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; BINDING SITES; CATALYSIS; CHLOROGENIC ACID; CONSERVED SEQUENCE; HIV INTEGRASE; HIV INTEGRASE INHIBITORS; HIV-1; HUMANS; ISOMERISM; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; POINT MUTATION; PROTEIN STRUCTURE, TERTIARY; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES; VIRUS INTEGRATION; VIRUS REPLICATION;

EID: 10244260392     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. LaFemina, R. L., C. L. Schneider, H. L. Bobbins, P. L. Callahan, K. LeGrow, E. Roth, W. A. Schleif, and E. A. Emini. Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells. J. Virol. 66:7414-7419 (1992).
2. Sakai, H., M. Kawamura, J. Sakuragi, S. Sakuragi, R. Shibata, A. Ishimoto, N. Ono, S. Ueda, and A. Adachi. Integration is essential for efficient gene expression of human immunodeficiency virus type 1. J. Virol. 67: 1169-1174 (1993).
3. Shin, C. G., B. Taddeo, W. A. Haseltine, and C. M. Farnet. Genetic analysis of the human immunodeficiency virus type 1 integrase protein. J. Virol. 68:1633-1642 (1994).
4. Englund, G., T. S. Theodore, E. O. Freed, A. Engleman, and M. A. Martin. Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1. J. Virol. 69:3216-3219 (1995).
5. Engleman, A., G. Englund, J. M. Orenstein, M. A. Martin, and R. Craigie. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J. Virol. 69:2729-2736 (1995).
6. Roth, M. J., P. Schwartzberg, N. Tanese, and S. P. Goff. Analysis of mutations in the integration function of Moloney murine leukemia virus: effect on DNA binding and cutting. J. Virol. 64:4709-4717 (1990).
7. Heinzinger, N. K., M. I. Bukrinsky, S. A. Haggerty, A. M. Ragland, V. Kewalramani, M.-A. Lee, H. Gendelman, L. Ratner, M. Stevenson, and M. Emerman. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA 91:7311-7315 (1994).
8. Bukrinsky, M. I., N. Sharova, T. L. McDonald, T. Pushkarskaya, W. G. Tarpley, and M. Stevenson. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc. Natl. Acad. Sci. USA 90: 6125-6129 (1993).
9. Bowerman, B., P. O. Brown, J. M. Bishop, and H. E. Varmus. A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev. 3:469-478 (1989).
10. Kahn, E., J. P. G. Mack, R. A. Katz, J. Kulkosky, and A. M. Skalka. Retroviral integrase domains: DNA binding and the recognition of LTR sequences. Nucleic Acids Res. 19:851-860 (1991).
11. Johnson, M. S., M. A. McClure, D.-F. Feng, J. Gray, and R. F. Doolittle. Computer analysis of retroviral pol genes: assignment of enzymatic functions to specific sequences and homologies with nonviral enzymes. Proc. Natl. Acad. Sci. USA 83:7648-7652 (1986).
12. Bushman, F. D., A. Engelman, I. Palmer, P. Wingfield, and R. Craigie. Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding. Proc. Natl. Acad. Sci. USA 90:3428-3432 (1993).
13. Dyda, F., A. B. Hickman, T. M. Jenkins, A. Engelman, R. Craigie, and D. R. Davies. Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. Science (Washington D. C.) 266:1981-1986 (1994).
14. Kulkosky, J., K. S. Jones, R. A. Katz, J. P. G. Mack, and A. M. Skalka. Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases. Mol. Cell. Biol. 12:2331-2338 (1992).
15. Engelman, A., and R. Craigie. Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro. J. Virol. 66:6361-6369 (1992).
16. Leavitt, A. D., L. Shiue, and H. E. Varmus. Site-directed mutagenesis of HIV-1 integrase demonstrates differential effects on integrase functions in vitro. J. Biol. Chem. 268:2113-2119 (1993).
17. Vink, C., A. M. Oude Groeneger, and R. H. Plasterk. Identification of the catalytic and DNA-binding region of the human immunodeficiency virus type I integrase protein. Nucleic Acids Res. 21:1419-1425 (1993).
18. Berg, J. M. Zinc fingers and other metal-binding domains. J. Biol. Chem. 265:6513-6516 (1990).
19. Vincent, K. A., V. Ellison, S. A. Chow, and P. O. Brown. Characterization of human immunodeficiency virus type 1 integrase expressed in Escherichia coli and analysis of variants with amino-terminal mutations. J. Virol. 67:425-437 (1993).
20. Ellison, V., and P. O. Brown. A stable complex between integrase and viral DNA ends mediates human immunodeficiency virus integration in vitro. Proc. Natl. Acad. Sci. USA 91:7316-7320 (1994).
21. Woerner, A. M., M. Klutch, J. G. Levin, and C. J. Marcus-Sekura. Localization of DNA binding activity of HIV-1 integrase to the C-terminal half of the protein. AIDS Res. Hum. Retroviruses 8:297-304 (1992).
22. Engelman, A., A. B. Hickman, and R. Craigie. The core and carboxylterminal domains of the integrase protein of human immunodeficiency virus type 1 each contribute to nonspecific DNA binding. J. Virol. 68:5911-5917 (1994).
23. Goff, S. P. Genetics of retroviral integration. Annu. Rev. Genet. 26:527-544 (1992).
24. Hickman, A. B., I. Palmer, A. Engelman, R. Craigie, and P. Wingfield. Biophysical and enzymatic properties of the catalytic domain of HIV-1 integrase. J. Biol. Chem. 269:29279-29287 (1994).
25. Fesen, M. R., K. W. Kohn, F. Leteurtre, and Y. Pommier. Inhibitors of human immunodeficiency virus integrase. Proc. Natl. Acad. Sci. USA 90:2399-2403 (1993).
26. Fesen, M. R., Y. Pommier, F. Leteurtre, S. Hiroguchi, J. Yung, and K. W. Kohn. Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochem. Pharmacol. 48:595-608 (1994).
27. Cushman, M., W. M. Golebiewski, Y. Pommier, A. Mazumder, D. Reymen, E. De Clercq, L. Graham, and W. G. Rice. Cosalane analogues with enhanced potencies as inhibitors of HIV-1 protease and integrase. J. Med. Chem. 38:443-452 (1995).
28. Cushman, M., and P. Sherman. Inhibition of HIV-1 integration protein by aurintricarboxylic acid monomers, monomer analogs, and polymer fractions. Biochem. Biophys. Res. Commun. 185:85-90 (1992).
29. LaFemina, R. L., P. L. Graham, K. LeGrow, J. C. Hastings, A. Wolfe, S. D. Young, E. A. Emini, and D. J. Hazuda. Inhibition of human immunodeficiency virus integrase by bis-catechols. Antimicrob. Agents Chemother. 39:320-324 (1995).
30. Robinson, W. E., Jr., M. G. Reinecke, S. Abdel-Malek, Q. Jia, and S. A. Chow. Inhibitors of HIV-1 replication that inhibit HIV integrase. Proc. Natl. Acad. Sci. USA 93:6326-6331 (1996).
31. Clifford, M. N. Coffee bean dicaffeoylquinic acids. Phytochemistry 25: 1767-1769 (1986).
32. Montefiori, D. C., W. E. Robinson, Jr., S. S. Schuffman, and W. M. Mitchell. Evaluation of antiviral drugs and neutralizing antibodies against human immunodeficiency virus by a rapid and sensitive microtiter infection assay. J. Clin. Microbiol. 26:231-235 (1988).
33. Veit, M., D. Strack, F.-C. Czygan, V. Wray, and L. Witte. Di-E-caffeoylmeso-tartaric acid in the barren sprouts of Equisetum arvense. Phytochemistry 30:527-529 (1991).
34. Wald, B., V. Wray, R. Galensa, and K. Hermann. Malonated flavonol glycosides and 3,5-dicaffeoylquinic acid from pears. Phytochemistry 28: 663-665 (1989).
35. Chow, S. A., K. A. Vincent, V. Ellison, and P. O. Brown. Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus. Science (Washington D. C.) 255:723-726 (1992).
36. Fletcher, R., and C. M. Reeves. Function minimization by conjugate gradients. Comput. J. 7:149-154 (1964).
37. Gabriel, J. L., and W. M. Mitchell. HIV gp120 docking interactions and inhibitor design based on an atomic structure derived by molecular modeling using the Dreiding II force field., in Protein Folds: A Distance Based Approach (H. Bohr and S. Brunak, eds.). CRC Press, Boca Raton, FL, 294-307 (1996).
38. Gabriel, J. L., and W. M. Mitchell. Proposed atomic structure of a truncated human immunodeficiency virus glycoprotein gp120 derived by molecular modeling: target CD4 recognition and docking mechanism. Proc. Natl. Acad. Sci. USA 90:4186-4190 (1993).
39. + target cells: a molecular model of gp120 predicts ligand binding. Drug Des. Disc., in press (1996).
40. van Gent, D. C., A. A. Oude Groeneger, and R. H. Plasterk. Identification of amino acids in HIV-2 integrase involved in site-specific hydrolysis and alcoholysis of viral DNA termini. Nucleic Acids Res. 21:3373-3377 (1993).